Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel for stomach cancer (FFCD Phase 3 trial)
2016-002331-16Phase 3Active
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Oct 2016
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of docetaxel in gastric cancer (GC), sponsored by Fédération Francophone de Cancérologie Digestive. Started Oct 2016; status: active.
02
Drugs
docetaxel
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on 2016-002331-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002331-16.